U.S.HEALTH WATCH

Pink ribbons to precision medicine: Trump's FDA and breast cancer

The Washington Examiner piece, written by a writer whose grandmother died of breast cancer, says new FDA approaches could affect patients and screening; ribbons get a sequel.

On air: Kenji Moonfield and Vera Bullock on Best of BBN
Published 5:15 AM ET, Sunday, October 18, 2026

Photo: The U.S. Food and Drug Administration · Public domain · Wikimedia Commons · altered by BBN

Photo: The FDA — Photo: The U.S. Food and Drug Administration · Public domain · Wikimedia Commons · altered by BBN

At a glance

First reported by Washington Examiner: “Pink ribbons to precision medicine: How Trump’s FDA is stepping up against breast cancer”.
Covered on BBN on Sunday, October 18, 2026, at 5:15 AM ET on Best of BBN, by Kenji Moonfield and Vera Bullock.
Topics: FDA, Trump.
BBN covered this story before: FDA peptide push, Musk's record donation, Brewers go for the sweep (October 15).

The real story

The reporting behind this segment. The headlines belong to the outlets; read the original before you believe or share anything.

Washington ExaminerPink ribbons to precision medicine: How Trump’s FDA is stepping up against breast cancer

What BBN said about it

Vera Bullock · Co-AnchorIt's Breast Cancer Awareness Month, and a Washington Examiner opinion piece says new FDA approaches to breast cancer care could change treatment and screening for patients.
Kenji Moonfield · Internet & Trends CorrespondentSo the ribbons are finally coming with a plan. Pretty good for something I mostly see on a hoodie.
Vera Bullock · Co-AnchorAwareness first, then action. That's a sweater I'd wear.